Delivery Order HHSN272201600008I-75N93020F00004
Award Date
9/1/20
Potential Completion Date
8/31/24
Potential Value
$229K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), is valued at $79,489.53. The contract was awarded to the prime contractor, Advanced Bioscience Laboratories, Inc. (ABL), to assist NIAID in planning and implementing two consultations focused on quality management systems and quality risk management for NIAID contractors and extramural programmatic staff. The contract has no set-aside...
This federal contract award is to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract is for the performance of toxicity testing for HIV proteins as part of NIAID's Preclinical Development Support program. The contract is a cost-plus-fixed-fee delivery order with a ceiling value of $1,050,558.51 and a period of performance through April 7, 2017....
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $174,091.42 cost-plus-fixed-fee contract is for planning and implementation of a NIAID consultation on advancing the development of multipurpose prevention technologies (MPTs). This is a delivery order issued under NIAID's HIV Microbicides and Biomedical Prevention 2016-2021 IDIQ...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $4,709,463.34, is for NIAID's Preclinical Development Support program focused on the immunoaffinity purification of HIV-1 envelope proteins. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type. This award does not have a...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious...
This federal contract award, valued at $572,349.48, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for material receipt, storage, shipping, and inventory services to support NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This is a Delivery Order under ABL's existing...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The $3,150,428.64 award is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL will provide comprehensive resources for HIV...
This federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) is for participation in a workshop on the development of animal models supporting pediatric formulation development. The $253,411.00 delivery order is part of the Resources to Advance Pediatrics and HIV Prevention Science contract vehicle from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). ABL is a leading contract research and manufacturing...
This federal contract award, valued at $2,959,434.41, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for the synthesis and production of an HIV-1 envelope glycopeptide immunogen nanoparticle vaccine as part of NIAID's Preclinical Development Support program. This is a cost-plus-fixed-fee delivery order contract with an ultimate...
This is a $6,095,159.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL) for expertise in professional pharmaceutical project management. The contract is issued under the larger Resources to Advance Pediatrics and HIV Prevention Science indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL, a manufacturer of biologics including vaccines and monoclonal antibodies,...